Syndecan-1/CD147 association is essential for cyclophilin B-induced activation of p44/42 mitogen-activated protein kinases and promotion of cell adhesion and chemotaxis-Reference-Cited by-同舟云学术

Syndecan-1/CD147 association is essential for cyclophilin B-induced activation of p44/42 mitogen-activated protein kinases and promotion of cell adhesion and chemotaxis

Published:2007-01-31 Issue:5 Volume:17 Page:492-503
ISSN:1460-2423
Container-title:Glycobiology
language:en
Short-container-title:

Author:

Pakula Rachel,Melchior Aurélie,Denys Agnès,Vanpouille Christophe,Mazurier Joël,Allain Fabrice

Publisher

Oxford University Press (OUP)

Subject

Biochemistry

Link

http://academic.oup.com/glycob/article-pdf/17/5/492/2228075/cwm009.pdf

Reference55 articles.

1. Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix;Allain;Proc Natl Acad Sci USA,2002

2. Extracellular cyclophilins contribute to the regulation of inflammatory responses;Arora;J Immunol,2005

3. Functions of cell surface heparan sulfate proteoglycans;Bernfield;Annu Rev Biochem,1999

4. Presence of cyclophilin A in synovial fluids of patients with rheumatoid arthritis;Billich;J Exp Med,1997

5. Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A;Brazin;Proc Natl Acad Sci USA,2002

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crosstalk Between Matrix Metalloproteinases and Their Inducer EMMPRIN/CD147: a Promising Therapeutic Target for Intracerebral Hemorrhage;Translational Stroke Research;2023-12-15

2. Immunotherapy for lung cancer combining the oligodeoxynucleotides of TLR9 agonist and TGF-β2 inhibitor;Cancer Immunology, Immunotherapy;2022-11-03

3. Cyclophilin B is really a major growth factor in breast milk;Journal of Biological Chemistry;2022-01

4. CypB promotes cell proliferation and metastasis in endometrial carcinoma;BMC Cancer;2021-06-29

5. Treatment of COVID-19 by stage: any space left for mesenchymal stem cell therapy?;Regenerative Medicine;2021-05